ACHIEVE GRX Registry

A Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Peripheral Vascular Interventions

This study will evaluate real-world performance of the CorPath GRX System in peripheral vascular interventions.

This is a prospective, single-arm, open-label, multi-center registry of the CorPath GRX System to evaluate its real-world performance during peripheral vascular interventions.

Inclusion Criteria:

1. Age ≥ 18 years.
2. Subject has a clinical indication for Peripheral Vascular Intervention (PVI).
3. Subject is deemed appropriate for robotic-assisted PVI.
4. The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
5. Individual monitoring of radiation dose, using the pocket dosimeter, was initiated at start of procedure.

Exclusion Criteria:

1. Failure/inability/unwillingness to provide informed consent.
2. The investigator determines the subject or the peripheral anatomy is not suitable for ro-botic-assisted PVI.
3. Women who are pregnant.